Vertex Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Vertex Pharmaceuticals Inc (VRTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 98.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Capital World Investors | 10.30 | 26,115,014 | +2.9 | 06/30/2026 |
| BlackRock Inc | 9.51 | 24,109,373 | +0.6 | 06/30/2026 |
| Capital Research Global Investors | 7.69 | 19,490,637 | -7.7 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.54 | 16,580,713 | +0.4 | 06/30/2026 |
| State Street Corp | 4.68 | 11,871,459 | +1.2 | 06/30/2026 |
| Amvescap Plc. | 3.17 | 8,043,052 | +1.9 | 06/30/2026 |
| JPMorgan Chase & Co | 2.57 | 6,517,600 | -7.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| American Funds Growth Fd of Amer A | 5.09 | 12,908,237 | +2.9 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.18 | 8,048,586 | -0.2 | 09/30/2026 |
| Vanguard 500 Index Investor | 2.63 | 6,654,794 | -1.3 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Sachdev Amit | EVP Chief Patient & Ext Af Off | 66,512 | 36,515,088 $ | Jul 21, 2026 | direct |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 53,572 | 29,411,028 $ | Jul 21, 2026 | direct |
| Sachs Bruce I | Director | 39,000 | 21,411,000 $ | Aug 27, 2026 | direct |
| Ambrose Kristen | SVP & Chief Accounting Officer | 11,624 | 6,381,576 $ | Aug 28, 2026 | direct |
| van Grunsven Jasper | EVP, CP and NPPO | 8,682 | 4,766,418 $ | Sep 8, 2026 | direct |
| Brennan Daniel J. | Director | 795 | 436,455 $ | Oct 20, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Brennan Daniel J. | Director | Other | 795 | 503.47 | 400,259 |
| Sep 8, 2026 | van Grunsven Jasper | EVP, CP and NPPO | Other | 8,682 | 0.00 | – |
| Aug 28, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Other | 5,000 | 0.00 | – |
| Aug 27, 2026 | Sachs Bruce I | Director | Other | 6,000 | 0.00 | – |
| Jul 21, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Other | 8,251 | 0.00 | – |
| Jul 21, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Other | 8,251 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.